Crossmark

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Published Online: 2022-03-21

Published Print: 2022-12

Authors

Ogrodniczak, Alicja http://orcid.org/0000-0003-2125-3106
Menkiszak, Janusz

Gronwald, Jacek

Tomiczek-Szwiec, Joanna

Szwiec, Marek

Cybulski, Cezary

Dębniak, Tadeusz

Huzarski, Tomasz

Tołoczko-Grabarek, Aleksandra

Byrski, Tomasz

Białkowska, Katarzyna

Prajzendanc, Karolina

Baszuk, Piotr

Lubiński, Jan

Jakubowska, Anna
License Information

Text and Data Mining valid from 2022-03-21

Version of Record valid from 2022-03-21
More Information

Article History

Received: 22 December 2021

Accepted: 8 March 2022

First Online: 21 March 2022

Declarations

:

: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Pomeranian Medical University in Szczecin (protocol code KB-0012/153/16 (BN-001/33/04), 20.12.2016).Informed consent was obtained from all subjects involved in the study.

: Not applicable

: The authors declare that they have no competing interests.

Document is current